ÇERİK, İ. B. Et Al. 2021. Impact of Adding Favipiravir to Hydroxychloroquine and Azithromycin Treatment on QTc Interval in COVID-19. Türkiye Klinikleri Cardiovascular Sciences , vol.33, no.1 , 15-21.

ÇERİK, İ. B., öztürk çerik, h., doğan, a., DERELİ, S., BEKTAŞ, O., & KAYA, Y., (2021). Impact of Adding Favipiravir to Hydroxychloroquine and Azithromycin Treatment on QTc Interval in COVID-19. Türkiye Klinikleri Cardiovascular Sciences , vol.33, no.1, 15-21.

ÇERİK, İDRİS Et Al. "Impact of Adding Favipiravir to Hydroxychloroquine and Azithromycin Treatment on QTc Interval in COVID-19," Türkiye Klinikleri Cardiovascular Sciences , vol.33, no.1, 15-21, 2021

ÇERİK, İDRİS B. Et Al. "Impact of Adding Favipiravir to Hydroxychloroquine and Azithromycin Treatment on QTc Interval in COVID-19." Türkiye Klinikleri Cardiovascular Sciences , vol.33, no.1, pp.15-21, 2021

ÇERİK, İ. B. Et Al. (2021) . "Impact of Adding Favipiravir to Hydroxychloroquine and Azithromycin Treatment on QTc Interval in COVID-19." Türkiye Klinikleri Cardiovascular Sciences , vol.33, no.1, pp.15-21.

@article{article, author={İDRİS BUĞRA ÇERİK Et Al. }, title={Impact of Adding Favipiravir to Hydroxychloroquine and Azithromycin Treatment on QTc Interval in COVID-19}, journal={Türkiye Klinikleri Cardiovascular Sciences}, year=2021, pages={15-21} }